Key result
Implantation of two HeartMate II ventricular assist devices for total artificial heart support in a 38-year-old man with cardiac sarcoma resulted in normal organ function and ambulation at 6 months.
Case Report (n=1)
Total artificial heart support using two continuous-flow ventricular assist devices is a feasible life-saving strategy for patients with primary cardiac sarcoma requiring cardiectomy.
May offer bridge option in cardiac sarcoma requiring cardiectomy; hypothesis-generating and needs prospective validation.
Primary cardiac sarcoma is normally fatal, but cardiac replacement may provide some hope for long-term survival. A 38 year-old man with cardiac sarcoma, involving the interventricular septum and posterior wall with intermittent mitral obstruction, underwent implantation of two HeartMate II ventricular assist devices for total artificial heart support. After cardiectomy, the HeartMate sewing rings were sewn to the right neoatrium and the left atrial remnants. After the outflow grafts were sewn end to end to the pulmonary artery and aorta, the two drivelines were externalized through the abdominal wall, and perfusion started. The postoperative course was complicated by respiratory and renal dysfunction, which resolved. After 6 months of support, the patient has normal organ function and is ambulatory. Follow-up oncologic evaluation of positron emission tomography-computed tomography scan is negative.
No takes yet. Share an insight, caveat, or question.
Pirk et al. (2013) conducted a case report in Primary cardiac sarcoma (n=1). Implantation of two HeartMate II ventricular assist devices for total artificial heart support was evaluated on Survival and organ function at 6 months. Implantation of two HeartMate II ventricular assist devices for total artificial heart support in a 38-year-old man with cardiac sarcoma resulted in normal organ function and ambulation at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: